Blackstone’s Oruka Therapeutics ORKA Stock Holding History
Bought
Maintained
Sold
Other funds holding ORKA
Blackstone's ORKA Position: Q2 2026 in Review
Blackstone opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 237,108 shares worth $22.6M. The stake represents 0.06% of the portfolio and ranks #74 among its holdings. This is a return to the name: Blackstone previously reported a position in ORKA as recently as Q4 2025.
Blackstone first reported a position in ORKA in Q4 2024 and has held it in 6 quarters since. The position peaked at $35.3M in Q4 2025. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.
- Blackstone held 237,108 shares of Oruka Therapeutics worth $22.6M as of Q2 2026.
- Oruka Therapeutics was a new Blackstone position in Q2 2026.
- Oruka Therapeutics made up 0.06% of Blackstone's portfolio in Q2 2026, its #74 holding.
- Blackstone first reported a position in Oruka Therapeutics in Q4 2024 and has held it in 6 quarters since.
- Blackstone's Oruka Therapeutics position peaked at $35.3M in Q4 2025.
- 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.
Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.